Allergies

New study published in Allergy confirms that allergy vaccination with Alutard SQ can prevent asthma

Published in Lab Law Weekly, September 7th, 2007

In the August issue of Allergy, a new study now confirms a long time scientific belief that allergy vaccination (also called specific immunotherapy) with Alutard SQ(R) early in the disease development can reduce the risk of developing the life threatening disease asthma in children suffering from allergic rhinitis due to grass and/or birch pollen allergy.

Allergic rhinitis is a major risk factor for later development of asthma. In the Preventive Allergy Treatment (PAT) study, 45% of children with allergic rhinitis not treated with Alutard SQ(R) developed asthma.

The main results from the PAT study concluded that the risk of developing asthma...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2007-09-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry